PA
UTMD icon

Perceptive Advisors’s Utah Medical Products UTMD Stock Holding History

Perceptive Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,828
Closed -$107K – 185
2015
Q4 		$107K Buy
+1,828
New +$104K 0.01% 147

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's UTMD Position: Q1 2016 in Review

Perceptive Advisors sold out of Utah Medical Products (UTMD) in Q1 2016, closing a stake of 1,828 shares — an estimated $107K sold.

Perceptive Advisors first reported a position in UTMD in Q4 2015 and held it in 1 quarter. The position peaked at $107K in Q4 2015. 68 funds tracked by Wall St. Rank hold UTMD as of Q1 2016.

  • Perceptive Advisors reported no remaining Utah Medical Products position as of Q1 2016 after selling out during the quarter.
  • Perceptive Advisors sold 1,828 Utah Medical Products shares in Q1 2016, an estimated $107K.
  • Perceptive Advisors first reported a position in Utah Medical Products in Q4 2015 and held it in 1 quarter.
  • Perceptive Advisors's Utah Medical Products position peaked at $107K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2016.

Based on Perceptive Advisors's 13F filing for Q1 2016, filed 16 May 2016.